|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 223.10 EUR | -0.84% |
|
+0.09% | -6.50% |
| Aug. 05 | UCB Publishes Results Of Post Hoc Data Analysis Of Fintepla In Patients With Lennox-Gastaut Syndrome | CI |
| Aug. 01 | UCB SA, H1 2026 Earnings Call, Jul 30, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- UCB Stock
- Consensus UCB
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
